BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND MYH11, ENSG00000133392, 4629 AND Treatment
12 results:

  • 1. Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission.
    Konuma T; Kondo T; Masuko M; Shimizu H; Shiratori S; Fukuda T; Kato J; Sawa M; Ozawa Y; Ota S; Uchida N; Kanda Y; Kako S; Fujisawa S; Fukushima K; Ichinohe T; Atsuta Y; Yanada M;
    Bone Marrow Transplant; 2021 Nov; 56(11):2779-2787. PubMed ID: 34272486
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Incidental identification of inv(16)(p13.1q22)/
    Quesada AE; Luthra R; Jabbour E; Patel KP; Khoury JD; Tang Z; Alvarez H; Mallampati S; Garcia-Manero G; Montalban-Bravo G; Medeiros LJ; Kanagal-Shamanna R
    Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117074
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation.
    Yang X; Shi J; Zhang X; Zhang G; Zhang J; Yang S; Wang J; Ke X; Fu L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31028135
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia.
    Ouyang J; Goswami M; Tang G; Peng J; Ravandi F; Daver N; Routbort M; Konoplev S; Lin P; Medeiros LJ; Jorgensen JL; Wang SA
    Am J Hematol; 2015 Jun; 90(6):504-10. PubMed ID: 25732229
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation.
    Yoon JH; Kim HJ; Kim JW; Jeon YW; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Lee JW; Min WS; Park CW
    Bone Marrow Transplant; 2014 Dec; 49(12):1466-74. PubMed ID: 25111512
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of class I and II aberrations in Iraqi childhood acute myeloid leukemia using filter paper cards.
    Al-Kzayer LF; Uyen le TN; Al-Jadiry MF; Al-Hadad SA; Al-Badri SA; Ghali HH; Ameen NA; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Hasan JG; Al-Abdullah HM; Al-Ani MH; Saber PA; Khalil HM; Inoshita T; Kamata M; Koike K; Sakashita K
    Ann Hematol; 2014 Jun; 93(6):949-55. PubMed ID: 24464319
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-myh11.
    Kanagal-Shamanna R; Zhao W; Vadhan-Raj S; Nguyen MH; Fernandez MH; Medeiros LJ; Bueso-Ramos CE
    Int J Environ Res Public Health; 2012 Aug; 9(8):2788-800. PubMed ID: 23066397
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Genotyping and minimal residual disease study in children with acute myeloid leukemia: preliminary results].
    Balwierz W; Pietrzyk JJ; Wator G; Stozek K; Klekawka T; Kwiecińska K; Dłuzniewska A; Matysiak M; Malinowska I; Sikorska-Fic B; Balcerska A; Maciejka-Kapuścińska L; Sońta-Jakimczyk D; Tomaszewska R; Chybicka A; Krawczuk-Rybak M; Muszyńska-Rosłan K; Młynarski W; Stolarska M; Urasiński T; Kamieńska E; Sobol G; Wieczorek M; Karolczyk G; Wysocki M; Kołtan S; Kowalczyk JR; Wójcik B; Ksiazek T; Szewczyk K
    Przegl Lek; 2010; 67(6):371-4. PubMed ID: 21344764
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia.
    Gutiérrez NC; López-Pérez R; Hernández JM; Isidro I; González B; Delgado M; Fermiñán E; García JL; Vázquez L; González M; San Miguel JF
    Leukemia; 2005 Mar; 19(3):402-9. PubMed ID: 15674361
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Granulocytic sarcoma of the small intestine with CBFbeta/myh11 fusion gene: report of an aleukaemic case and review of the literature.
    Xavier SG; Fagundes EM; Hassan R; Bacchi C; Conchon M; Tabak DG; Spector N; Zalcberg IR
    Leuk Res; 2003 Nov; 27(11):1063-6. PubMed ID: 12859999
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Quantification of CBFbeta/myh11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
    Marcucci G; Caligiuri MA; Döhner H; Archer KJ; Schlenk RF; Döhner K; Maghraby EA; Bloomfield CD
    Leukemia; 2001 Jul; 15(7):1072-80. PubMed ID: 11455976
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular and clinical advances in core binding factor primary acute myeloid leukemia: a paradigm for translational research in malignant hematology.
    Marcucci G; Caligiuri MA; Bloomfield CD
    Cancer Invest; 2000; 18(8):768-80. PubMed ID: 11107447
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.